When Will The Rally In Precipio's Stock End?

Shares of cancer diagnostics company Precipio, Inc. PRPO have soared 170% this week after the company said it launched a COVID-19 test on the Amazon.com, Inc. AMZN business platform.

A similar thing happened in July when Precipio first announced its COVID-19 strategy. Shares made an even larger move than they did this week.

Investors should focus on two key levels.

In July, shares reached $8, but by the close, they backed off to $7. Levels that had previously been resistance can become resistance again. If PRPO reaches these levels, there is a good chance the rally stalls out at them once more.